NCT06156241View on ClinicalTrials.gov

Stem Cell Study for Long COVID-19 Neurological Symptoms

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

February 28, 2026

Conditions
Post-Acute COVID-19 Syndrome
Interventions
BIOLOGICAL

Stem Cell

Stem cells derived from human cord tissue.

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

Sponsors

Collaborators (1)

CBR Systems, Inc.
All Listed Sponsors
collaborator

CBR Systems, Inc.

OTHER

lead

Charles Cox

OTHER